Internal Metabolomic Biomarker Exposome and Developmental Disorders (IMBEDD) (Q20): Difference between revisions
Changed an Item |
Changed an Item |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / participant life stages | |||
| Property / participant life stages: Maternal Prenatal Stage / rank | |||
Normal rank | |||
| Property / primary health outcomes | |||
| Property / primary health outcomes: cognitive disorder / rank | |||
Normal rank | |||
| Property / identifier | |||
2016-1438 | |||
| Property / identifier: 2016-1438 / rank | |||
Normal rank | |||
| Property / geographic location description | |||
Sacramento, University of California Davis MIND Institute in Sacramento | |||
| Property / geographic location description: Sacramento, University of California Davis MIND Institute in Sacramento / rank | |||
Normal rank | |||
Latest revision as of 00:08, 20 December 2024
The MARBLES (Markers of Autism Risk in Babies: Learning Early Signs) prospective study of over 450 high-risk pregnancies recruits mothers who have a child with confirmed ASD and are either planning a pregnancy or are pregnant with another child, in o
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Internal Metabolomic Biomarker Exposome and Developmental Disorders (IMBEDD) |
The MARBLES (Markers of Autism Risk in Babies: Learning Early Signs) prospective study of over 450 high-risk pregnancies recruits mothers who have a child with confirmed ASD and are either planning a pregnancy or are pregnant with another child, in o |
Statements
#R01ES020392; NIEHS P01ES011269; EPA RD82938801;NIEHS (P01ES011269) and EPA (RD82938801). EPA 83543201;R01ES025574 ; R01ES028089; R21ES025551;P01ES011268-13S2) under PA-15-123 DOD: AR110194.
0 references
Internal Metabolomic Biomarker Exposome and Developmental Disorders (IMBEDD)
0 references
Schmidt, Rebecca
0 references
567
0 references
2016-1438
0 references
Sacramento, University of California Davis MIND Institute in Sacramento
0 references